Article

Double minute in acute myeloid leukemia and myelodysplastic syndrome: Identification of new amplification regions by fluorescence in situ hybridization and spectral karyotyping

Clinical Cytogenetics Laboratory, Roswell Park Cancer Institute, Buffalo, New York 14263, USA.
Genes Chromosomes and Cancer (Impact Factor: 3.84). 05/2002; 34(1):42-7. DOI: 10.1002/gcc.10038
Source: PubMed

ABSTRACT Double minute chromosomes (dmin) are small chromatin bodies consisting of genes amplified in an extrachromosomal location. dmins are uncommon in hematologic malignancies; they are seen primarily in acute myeloid leukemia, with amplification of the MYC oncogene or, less frequently, the MLL transcription factor. Nine patients with hematologic malignancies with dmin were seen at the Roswell Park Cancer Institute between 1985 and 2000; eight had acute myeloid leukemia and one a myelodysplastic syndrome. Fluorescence in situ hybridization (FISH) demonstrated MYC amplification on dmin in four patients, but MLL amplification was not seen. Spectral karyotyping showed that the dmin derived from chromosome 11 in one patient and from chromosome 19 in two others without MYC or MLL amplification; derivation from these chromosomes was confirmed by FISH with chromosome paint probes. The dmin of chromosome 11 origin hybridized to a bacterial artificial chromosome (BAC) RP11-112M22 that maps to 11q24.3 and is predicted to contain ETS1 and other markers, including D11S11351 and D11S4091. The dmin of chromosome 19 origin in one patient hybridized to BACs RP11-46I12 and RP11-110J19; in the other patient, these clones did not hybridize with the dmin, but were found to be amplified on a marker chromosome that was derived from chromosome 19 in that patient's cells. These BACs have been mapped to 19q12-19q13.1 and 19q11-19q13.1, respectively, and are predicted to contain the markers D19S409 and D19S919 and the gene for ubiquinol-cytochrome C reductase, Rieske iron-sulfur polypeptide1 (UQCRFS1). dmin originating from chromosome 19 have not been reported previously in hematologic malignancies.

0 Followers
 · 
64 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: AML/MDS patients carrying 11q amplifications involving the mixed lineage leukemia gene (MLL) locus are characterized by a complex aberrant karyotype (CAK) frequently including deletions within 5q, 17p, and 7q, older age and fast progression of the disease with extremely poor prognosis. MLL has been shown to be overexpressed in cases with 11q amplification. However, in most of the cases, the amplified region is not restricted to the MLL locus. In this study, we investigated 19 patients with AML/MDS and MLL gain/amplification. By means of array CGH performed in 12 patients, we were able to delineate the minimal deleted regions within 5q and 17p and identified three independent regions 11q/I-III that were amplified in all cases. Gene expression profiles established in 15 cases were used to identify candidate genes within these regions. Notably, analysis of our data suggests a correlation of loss of 5q and 17p and expression of genes present in 11q23-25. Furthermore, we demonstrate that the gene expression signature can be used to discriminate AML/MDS with MLL amplification from several other types of AML.
    Genes Chromosomes and Cancer 06/2009; 48(6):510-20. DOI:10.1002/gcc.20658 · 3.84 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Spectral karyotyping (SKY) is a widely used methodology to identify genetic aberrations. Multicolor fluorescence in situ hybridization using chromosome painting probes in individual colors for all metaphase chromosomes at once is combined with a unique spectral measurement and analysis system to automatically classify normal and aberrant chromosomes. Based on countless studies and investigations in many laboratories worldwide, numerous new chromosome translocations and other aberrations have been identified in clinical and tumor cytogenetics. Thus, gene identification studies have been facilitated resulting in the dissection of tumor development and progression. For example, different translocation partners of the TEL/ETV6 transcription factor that is specially required for hematopoiesis within the bone marrow were identified. Also, the correct classification of complex karyotypes of solid tumors supports the prognostication of cancer patients. Important accomplishments for patients with genetic diseases, leukemias and lymphomas, mesenchymal tumors and solid cancers are summarized and exemplified. Furthermore, studies of disease mechanisms such as centromeric DNA breakage, DNA double strand break repair, telomere shortening and radiation-induced neoplastic transformation have been accompanied by SKY analyses. Besides the hybridization of human chromosomes, mouse karyotyping has also contributed to the comprehensive characterization of mouse models of human disease and for gene therapy studies.
    Cytogenetic and Genome Research 02/2006; 114(3-4):199-221. DOI:10.1159/000094203 · 1.91 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Sechs verschiedene Tumorzelllinien aus duktalen Pankreaskarzinomen transgener TGFalpha/p53+/-M?se wurden molekular-zytogenetisch durch Spectral Karyotyping analysiert, um Hinweise auf sekund?e genetische Ver?derungen zu erhalten, die f? die Tumorgenese in diesem Mausmodell verantwortlich sind. Es wurden haupts?hlich numerische Abberationen mit hypertriploiden bis hypotetraploiden Karyotypen detektiert, wohingegen durchschnittlich nur 4,3 Strukturaberrationen pro Metaphase nachgewiesen werden konnten. Fast immer stellten sich einige kleine Markerchromosomen dar, die durch SKY nicht eindeutig identifiziert werden konnten. Auff?ligste Ver?derung der Zelllinie TD2 (MMUPaTu7 und 8=7B) war ein gro?s Markerchromosom, dessen proximaler Anteil mit drei charakteristischen dunklen Banden aus Material von Chromosom 11 bestand, w?rend der distale Abschnitt zu Chromosom 5 geh?te. Durch FISH-Analyse mit spezifischen BAC-Proben f? das Chromosom 11 konnte hierf? eine Amplifikation der Kandidatengene Egfr und c-Rel festgestellt werden. Auch in den anderen Zelllinien traten geh?ft Strukuraberrationen des Chromosoms 11 auf, f? die ebenfalls eine Beteiligung dieser Genloci postuliert werden kann. Weitere strukturelle Ver?derungen betrafen Chromosom 15 mit c-Myc-Amplifikationen in Form von extrachromosomalen "double minutes", welche in h?eren Passagen der Zelllinie TD2 als homogeneously stained regions (HSR) integriert an variablen Positionen des Chromosoms 6 sichtbar wurden. In den analysierten Metaphasen trat zus?zlich h?fig ein vergrößertes Chromosom 8 auf, allerdings im Bandenmuster mit unterschiedlichen Amplifikationseinheiten, wobei ein Gewinn des dort lokalisierten Transkriptionsfaktors Jun-B m?lich w?e. F? eine genauere Charakterisierung der in die verschiedenen Strukturaberrationen involvierten Kandidatengene sind gezielte FISH-Analysen mit lokusspezifischen BAC-Proben oder andere weiterf?rende molekular-genetische Untersuchungen erforderlich. x